Identification of Oral Lesions Through an Autofluorescence System

Sponsor
Federico II University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05942794
Collaborator
(none)
200
1
1
4
49.9

Study Details

Study Description

Brief Summary

The aim of the study will be to evaluate the efficacy of a tissue autofluorescence detection system as an aid to clinical screening in identifying lesions of the oral mucosa. The screening process will be performed by 3 clinicians with a different level of experience. Sensitivity and specificity tests will be conducted.

Condition or Disease Intervention/Treatment Phase
  • Device: Screening examination
N/A

Detailed Description

Tissue autofluorescence analysis will be performed using GOOCLES® glasses, a device capable of detecting variations in fluorescence when the examined area is illuminated with a common photopolymerising lamp. Three clinical professionals will be identified:

  • Dental hygienist (1);

  • General dentist (2);

  • Dentist expert in Medicine and Oral Pathology (3).

All patients will be included in the study after receiving an initial dental visit, in order to rule out patients with noticeable oral lesions.

Dental hygienist (1) will collect the patient's data by filling the "anamnestic record". Furthermore, (1) will perform the first clinical examination (with and without GOOCLES®), reporting his observations on his own "operator module".

The same screening (with and without GOOCLES®) will be conducted blindly by the general dentist (2) who, if he deems it necessary, will refer the patient to the oral pathologist (3), who will confirm or not (with and without GOOCLES®) the presence of an oral region such as to be further investigated (follow up or biopsy) and will report the observations on its own "operator module".

Inter-operator and intra-operator comparisons will be performed and the data thus obtained will be processed for statistical processing.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
The screening will start after a first oral examination, in order to rule out noticeable mucosal lesions.The screening will start after a first oral examination, in order to rule out noticeable mucosal lesions.
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Use of a Tissue Autofluorescence Detection System for Identification of Oral Mucosal Lesions
Actual Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Screening examination

All patients will undergo a screening examination (with or without GOCCLES ® glasses) by all three operators.

Device: Screening examination
After an initial clinical visit, all three operators will wear the tissue autofluorescence detection device (GOCCLES®), reporting both observations on their "operator-module".

Outcome Measures

Primary Outcome Measures

  1. Clinical change of oral mucosa [baseline and after 21 days]

    Presence of a white, red, or mixed mucosal area with an exophytic or vegetative appearance or with loss of substance

  2. Fluorescence change of oral mucosa [baseline and after 21 day]

    Presence of a mucosal area with reduced or increased fluorescence

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male and female;

  • Age ≥ 18 years;

  • Non-smokers and smokers

Exclusion Criteria:
  • Cancer patients;

  • Patients presenting a histological diagnosis of oral mucosal dysplasia/carcinoma.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Naples Federico II Napoli Italy 80131

Sponsors and Collaborators

  • Federico II University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Luca Ramaglia, Clinical Professor, Federico II University
ClinicalTrials.gov Identifier:
NCT05942794
Other Study ID Numbers:
  • 177/2023
First Posted:
Jul 12, 2023
Last Update Posted:
Jul 17, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Luca Ramaglia, Clinical Professor, Federico II University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 17, 2023